Defymed is a company that develops and markets implantable bio-artificial medical devices for diverse therapeutic applications.Watch the video
Our basic aim is to develop breakthrough innovations that enhance drug delivery systems leading to improvements in the quality of life of patients.Séverine Sigrist, Defymed CEO Who are we ?
Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
A bio-artificial pancreas intended to be filled with insulin-secreting cells in order to regulate blood glucose levels in a more physiological wayMore about MailPan ®
February 01 2023
22-25 February (Berlin, Germany): Defymed at the Advanced Technologies and treatments for Diabetes T...
August 09 2022
4-8 September: Defymed at the annual conference of the European Society for Biomaterials (ESB) Elisa...